Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain

J Clin Microbiol. 2015 Aug;53(8):2741-4. doi: 10.1128/JCM.01057-15. Epub 2015 Jun 10.

Abstract

This study gathered information about current practices of cytomegalovirus (CMV) infection management in allogeneic stem cell transplant recipients at Spanish centers. A wide variety of preemptive antiviral therapy strategies for CMV infection guided by real-time PCR assays was found, yet the incidence of CMV disease was low (<3%).

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Case Management
  • Chemoprevention / methods*
  • Cytomegalovirus Infections / diagnosis*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / prevention & control*
  • Humans
  • Molecular Diagnostic Techniques / methods*
  • Real-Time Polymerase Chain Reaction
  • Spain
  • Stem Cell Transplantation / adverse effects*
  • Transplantation, Homologous / adverse effects*

Substances

  • Antiviral Agents